About Catalyst Regulatory Services
Catalyst Regulatory Services is a Healthcare company based in Chelsea (United States) founded in 2012 by John P Balser and Barbara Balser, and was acquired by Veristat in December 2019. Drug design, development, and regulatory consulting services are provided. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.
Company details
Catalyst Regulatory Services was established in 2012 in Chelsea, United States, within the pharmaceutical sector. Drug designing, development, and consulting services are delivered to support regulatory needs. Operations focus on compliance and advisory roles for pharmaceutical projects. The company is led by co-founders John P. Balser as owner and Barbara Balser as chief scientific officer. Geographic emphasis remains on the U.S. market.
- Headquarters Chelsea, United States
- Founders John P Balser, Barbara Balser
- Stage Acquired
- SectorsHealthcare
- Website catalystreg.com
- Acquired by Veristat (Dec 2019)
Investors in Catalyst Regulatory Services
Catalyst Regulatory Services has secured backing from 1 investor. Prominent investors backing the company include Veristat.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical trials and regulatory submissions are supported as a CRO. | 1994 | veristat.com | Southborough, United States |
Investor details for Catalyst Regulatory Services
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Catalyst Regulatory Services
2 people are tracked at Catalyst Regulatory Services (2 in leadership).
| Name | Role | Group |
|---|---|---|
John P Balser | Co-Founder & Owner | Leadership |
Barbara Balser | Co-Founder & CSO | Leadership |
Complete people profiles for Catalyst Regulatory Services
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Catalyst Regulatory Services
2 dated milestones of Catalyst Regulatory Services across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Catalyst Regulatory Services is founded.
- Exit Acquired by Veristat.
Competitors of Catalyst Regulatory Services
Catalyst Regulatory Services has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clearviewhcp.com | 2008 | Newton, United States | 381 | Strategic consulting services are provided to life sciences companies. |
Detailed competitors of Catalyst Regulatory Services
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Catalyst Regulatory Services (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Catalyst Regulatory Services
Catalyst Regulatory Services was founded in 2012.
Catalyst Regulatory Services is headquartered in Chelsea, United States. It is registered at Chelsea, Massachusetts, United States.
Catalyst Regulatory Services was established in 2012 in Chelsea, United States, within the pharmaceutical sector. Drug designing, development, and consulting services are delivered to support regulatory needs. Operations focus on compliance and advisory roles for pharmaceutical projects. The company is led by co-founders John P. Balser as owner and Barbara Balser as chief scientific officer. Geographic emphasis remains on the U.S. market.
Catalyst Regulatory Services's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.
Catalyst Regulatory Services has 1 investor. Key investors include Veristat.
Yes. Catalyst Regulatory Services was acquired by Veristat in December 2019.